Nissim Darvish

Senior Managing Director at OrbiMed Advisors LLC

Nissim Darvish

Nissim Darvish

Senior Managing Director at OrbiMed Advisors LLC

Overview
Career Highlights

Impulse Dynamics USA, Inc.
Atria Medical, Inc.

RelSci Relationships

353

Number of Boards

19

Birthday

1965

Age

54

Contact Data
Trying to get in touch with Nissim Darvish? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Nissim Darvish likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Director at Orbimed Israel Partners LP

Relationship likelihood: Strong

Senior Managing Director at OrbiMed Advisors LLC

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Keystone Heart Ltd.

Relationship likelihood: Strong

Venture Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Venture Partner at OrbiMed Advisors LLC

Relationship likelihood: Strong

Chairman & Founder at Tisbury Pharmaceuticals Ltd.

Relationship likelihood: Strong

Chief Executive Officer & Director at SmartZyme Biopharma, Inc.

Relationship likelihood: Strong

Investor at Valence Health, Inc.

Relationship likelihood: Strong

Chief Executive Officer at ValCare Medical, Inc.

Relationship likelihood: Strong

Paths to Nissim Darvish
Potential Connections via
Relationship Science
You
Nissim Darvish
Senior Managing Director at OrbiMed Advisors LLC
Education
Doctorate

The Technion – Israel Institute of Technology (Hebrew: ??????? – ???? ???????? ???????) is a public research university in Haifa, Israel. Founded in 1912, Technion is the oldest university in Israel. The university offers degrees in science and engineering, and related fields such as architecture, medicine, industrial management and education. The Technion was conceived in the early 1900s by the German-Jewish fund Ezrah as a school of engineering and sciences. It was to be the only institution of higher learning in the then Ottoman Palestine, other than the Bezalel Academy of Art and Design in Jerusalem (founded in 1907).

Career History
Senior Managing Director
Current

OrbiMed Advisors focuses on investments in the global healthcare industry. They utilizes strategies based on evaluating pharmaceutical, biotechnology, medical device, healthcare services and other companies in the global healthcare sector. The instruments in which OrbiMed invests include US and non-US equities, both long and short, as well as privately placed securities, debt securities, royalty bonds and other royalty instruments, currencies, private investments in public equity securities (PIPEs), ETFs, index options, and derivatives (including swap agreements). The firm invests across the global healthcare industry, from seed-stage venture capital to large publicly-traded companies. Investments are made across three strategies: public equity, private equity, and royalty opportunities. OrbiMed Advisors manages a series of public equity funds, including long/short event-driven funds and closed-end investment trusts. They invest across all types of publicly-traded companies, from biopharmaceuticals to medical devices and healthcare services worldwide. OrbiMed's private equity strategy is broad and flexible, investing from start-ups through growth equity. OrbiMed is typically a lead investor, seeking to help build our portfolio companies. Their geographic focus includes North America, Asia, Europe and Israel. For Royal Opportunities strategy, OrbiMed provides commercial-stage healthcare companies with non-dilutive structured debt capital. Additionally, they can monetize royalty streams, providing valuable financing solutions to owners of intellectual property.

General Partner
2002 - 2010

Pitango is a hands-on manager which invests in seed, early, expansion and later-stage companies, aiming to identify their hidden potential and transform them into world-class business ventures. The firm establishes dedicated and informal working relationships with entrepreneurs, nurturing, guiding and opening up opportunities for investee companies.Pitango seeks to invest in high growth technology companies which have: a solid management team with the right mix of vision, creativity, energy, commitment, business experience and integrity; a novel idea that fulfills a significant need in a high-growth sector, and that in time can grow into a coherent product line; substantial technology and intellectual property that can create significant barriers to entry and knowledge of relevant markets, competitors and business models.The firm acts as lead investor, seeking a board seat on companies in the communications, enterprise software and internet infrastructure, network and storage, wireless technologies, life sciences, internet and media, nanotechnology and clean technology sectors. In partnership with investee company management, they aim to provide value-added services designed to accelerate time-to-market and give companies an advantage in the high-tech marketplace.

Inventor
1996 - 2001

MetaCure (USA), Inc. engages in the development and commercialization of invasive treatment for diabetes. The company was founded by Shlomo Ben-Haim in 2003 and is headquartered in Orangeburg, NY.

Boards & Committees
Member, Board of Directors
2015 - Current

SmartZyme Biopharma, Inc. provides platform for protein design and engineering in accordance with industry required specifications. The company was founded by David Baram and Shilo Ben Zeev in 2013 and is headquartered in Ness Ziona, Israel.

Director
Current

TytoCare Ltd. develops handheld devices and telehealth platform. Its products include TytoHome, TytoPro and TytoClinic. The firm specializes in medical devices, digital health, consumer, home monitoring and mobile health. The company was founded by Dedi Gilad and Ofer Tzadik in 2012 and is headquartered in Netanya, Israel.

Director
Current

ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel.

Investments
Details Hidden

Blue Surgical Ltd. develops medical devices for the treatment of obesity. The company was founded by Eli Bar and Nissim Darvish in August 2006 and is headquartered in Qiryat Shemona, Israel.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Nissim Darvish. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Nissim Darvish's profile does not indicate a business or promotional relationship of any kind between RelSci and Nissim Darvish.